{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:08:38Z","timestamp":1767913718396,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,9]]},"DOI":"10.7759\/cureus.27820","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T16:26:04Z","timestamp":1660062364000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful Management of Hemodynamically Unstable Takotsubo Cardiomyopathy With Milrinone"],"prefix":"10.7759","author":[{"given":"Karan H","family":"Pahuja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natale","family":"Wasef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tehreem","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Seelagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg096","article-title":"The clinical features of Takotsubo cardiomyopathy","volume":"96","author":"Akashi YJ","year":"2003","unstructured":"Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Koike H, Sasaka K. The clinical features of Takotsubo cardiomyopathy. QJM. 2003, 96:563-73. 10.1093\/qjmed\/hcg096","journal-title":"QJM"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153801.51470.EB","article-title":"Acute and reversible cardiomyopathy provoked by stress in women from the United States","volume":"111","author":"Sharkey SW","year":"2005","unstructured":"Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, Maron BJ. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005, 111:472-9. 10.1161\/01.CIR.0000153801.51470.EB","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.027121","article-title":"Pathophysiology of Takotsubo syndrome","volume":"135","author":"Pelliccia F","year":"2017","unstructured":"Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo syndrome. Circulation. 2017, 135:2426-41. 10.1161\/CIRCULATIONAHA.116.027121","journal-title":"Circulation"},{"key":"ref4","article-title":"Takotsubo cardiomyopathy","author":"Ahmad S","year":"2022","unstructured":"Ahmad S, Brito D, Khalid N, et al.. Takotsubo cardiomyopathy. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6556","article-title":"Management of Takotsubo syndrome: a comprehensive review","volume":"12","author":"Sattar Y","year":"2020","unstructured":"Sattar Y, Siew KS, Connerney M, Ullah W, Alraies MC. Management of Takotsubo syndrome: a comprehensive review. Cureus. 2020, 12:10.7759\/cureus.6556","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-010-2113-0","article-title":"Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)","volume":"37","author":"Follath F","year":"2011","unstructured":"Follath F, Yilmaz MB, Delgado JF, et al.. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). Intensive Care Med. 2011, 37:619-26. 10.1007\/s00134-010-2113-0","journal-title":"Intensive Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2014.03.007","article-title":"Tako-Tsubo cardiomyopathy presenting with cardiogenic shock successfully treated with milrinone: a case report","volume":"43","author":"Doyen D","year":"2014","unstructured":"Doyen D, Dellamonica J, Moceri P, Moschietto S, Hyvernat H, Ferrari E, Bernardin G. Tako-Tsubo cardiomyopathy presenting with cardiogenic shock successfully treated with milrinone: a case report. Heart Lung. 2014, 43:331-3. 10.1016\/j.hrtlng.2014.03.007","journal-title":"Heart Lung"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90834-5","article-title":"Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure","volume":"121","author":"Mager G","year":"1991","unstructured":"Mager G, Klocke RK, Kux A, H\u00f6pp HW, Hilger HH. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure. Am Heart J. 1991, 121:1974-83. 10.1016\/0002-8703(91)90834-5","journal-title":"Am Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2016.06.007","article-title":"Successful treatment of inverted Takotsubo cardiomyopathy after severe traumatic brain injury with milrinone after dobutamine failure","volume":"45","author":"Mrozek S","year":"2016","unstructured":"Mrozek S, Srairi M, Marhar F, et al.. Successful treatment of inverted Takotsubo cardiomyopathy after severe traumatic brain injury with milrinone after dobutamine failure. Heart Lung. 2016, 45:406-8. 10.1016\/j.hrtlng.2016.06.007","journal-title":"Heart Lung"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2019.10.038","article-title":"An exceptional cause of acute right heart failure: isolated right ventricular Takotsubo syndrome","volume":"2","author":"Carreras-Mora J","year":"2020","unstructured":"Carreras-Mora J, Duran-Cambra A, Vilades-Medel D, et al.. An exceptional cause of acute right heart failure: isolated right ventricular Takotsubo syndrome. JACC Case Rep. 2020, 2:365-9. 10.1016\/j.jaccas.2019.10.038","journal-title":"JACC Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14744\/AnatolJCardiol.2018.78642","article-title":"Dobutamine-induced Takotsubo cardiomyopathy: a systematic review of the literature and case report","volume":"19","author":"Hajsadeghi S","year":"2018","unstructured":"Hajsadeghi S, Rahbar MH, Iranpour A, Salehi A, Asadi O, Jafarian SR. Dobutamine-induced Takotsubo cardiomyopathy: a systematic review of the literature and case report. Anatol J Cardiol. 2018, 19:412-6. 10.14744\/AnatolJCardiol.2018.78642","journal-title":"Anatol J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8175.2009.01089.x","article-title":"Takotsubo cardiomyopathy induced by dobutamine infusion: a new phenomenon or an old disease with a new name","volume":"27","author":"Mosley WJ 2nd","year":"2010","unstructured":"Mosley WJ 2nd, Manuchehry A, McEvoy C, Rigolin V. Takotsubo cardiomyopathy induced by dobutamine infusion: a new phenomenon or an old disease with a new name. Echocardiography. 2010, 27:30-3. 10.1111\/j.1540-8175.2009.01089.x","journal-title":"Echocardiography"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2007.03.018","article-title":"Levosimendan: the inotrope of choice in cardiogenic shock secondary to Takotsubo cardiomyopathy?","volume":"16","author":"Padayachee L","year":"2007","unstructured":"Padayachee L. Levosimendan: the inotrope of choice in cardiogenic shock secondary to Takotsubo cardiomyopathy?. Heart Lung Circ. 2007, 16:65-70. 10.1016\/j.hlc.2007.03.018","journal-title":"Heart Lung Circ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs215","article-title":"Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study","volume":"15","author":"Husebye T","year":"2013","unstructured":"Husebye T, Eritsland J, M\u00fcller C, et al.. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study. Eur J Heart Fail. 2013, 15:565-72. 10.1093\/eurjhf\/hfs215","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew R","year":"2021","unstructured":"Mathew R, Di Santo P, Jung RG, et al.. Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med. 2021, 385:516-25. 10.1056\/NEJMoa2026845","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105417-successful-management-of-hemodynamically-unstable-takotsubo-cardiomyopathy-with-milrinone","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:34Z","timestamp":1707507454000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105417-successful-management-of-hemodynamically-unstable-takotsubo-cardiomyopathy-with-milrinone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.27820","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}